Lincoln Pharmaceuticals Ltd
Company Profile
Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
INDT: +91 7941078000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,853
Stocks News & Analysis
stocks
Have the 3 biggest losers of the ASX 200 fallen too far?
stocks
Rethinking the way we invest in Aussie tech
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,883.80 | 39.20 | -0.44% |
| CAC 40 | 8,122.71 | 23.24 | 0.29% |
| DAX 40 | 23,836.79 | 68.83 | 0.29% |
| Dow JONES (US) | 47,716.42 | 289.30 | 0.61% |
| FTSE 100 | 9,720.51 | 26.58 | 0.27% |
| HKSE | 26,046.41 | 187.52 | 0.73% |
| NASDAQ | 23,365.69 | 151.00 | 0.65% |
| Nikkei 225 | 49,407.31 | 846.60 | -1.68% |
| NZX 50 Index | 13,443.04 | 46.11 | -0.34% |
| S&P 500 | 6,849.09 | 36.48 | 0.54% |
| S&P/ASX 200 | 8,583.20 | 30.90 | -0.36% |
| SSE Composite Index | 3,900.34 | 11.74 | 0.30% |